+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The true value of serum elastase-1 in endoscopic retrograde cholangiopancreatography (ERCP)



The true value of serum elastase-1 in endoscopic retrograde cholangiopancreatography (ERCP)



European Journal of Internal Medicine 13(5): 329-335



BACKGROUND: The routine use of serum elastase-1 in patients, pre- and post-endoscopic retrograde cholangiopancreatography (ERCP), has been strongly supported but not sufficiently correlated with diagnosis, patient outcome/prognosis, or routine markers such as serum amylase. The value of serum elastase-1 post-ERCP, as far as clinical diagnosis and prognosis is concerned, was tested and compared with serum amylase in terms of sensitivity, specificity, positive prognostic value (PPV), and negative prognostic value (NPV). METHODS: In a prospective study of 38 consecutive patients undergoing ERCP, we assessed the following biochemical parameters 24 h before ERCP and 2 and 18 h after ERCP: alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (gamma-GT), alkaline phosphatase (ALP), amylase (AMS), lactate dehydrogenase (LDH), and pancreatic elastase-1. RESULTS: Statistically significant changes were found between pre-ERCP and 18-h post-ERCP in elastase-1 (P=0.009), amylase (P=0.016), gamma-GT (P=0.04), and ALP (P=0.04). Changes between 2-h and 18-h post-ERCP in all parameters tested were not statistically significant. No statistical significance was found between any biochemical parameter and specific ERCP diagnosis. CONCLUSIONS: This study showed that 2-h post-ERCP serum elastase-1 was 100% specific for post-ERCP pancreatitis or other underlying severe pathology while, at the same time, amylase was only 50% specific. The specificity of serum elastase-1 still remained high (87.5%) 18-h post-ERCP, while amylase only had a specificity of 25% at that time. In contrast, amylase had a sensitivity of 83.3 and 90% in the 2-h and 18-h post-ERCP serum samples, while elastase-1 only had a sensitivity of 56.7 and 73.3%, respectively.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047750780

Download citation: RISBibTeXText

PMID: 12144913

DOI: 10.1016/s0953-6205(02)00082-1


Related references

Value of magnetic-resonance cholangiopancreatography (MRCP) after unsuccessful endoscopic-retrograde cholangiopancreatography (ERCP). Gastrointestinal Endoscopy 49(2): 265-266, 1999

Endoscopic retrograde cholangiopancreatography (ERCP) outcomes can improve after further training for an individual already experienced in ERCP. Minerva Gastroenterologica e Dietologica 61(3): 117-120, 2015

Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis. Gastrointestinal Endoscopy Clinics of North America 25(1): 107-121, 2015

Diathermy ERCP: an alternative method for endoscopic retrograde cholangiopancreatography (ERCP) in jaundiced patients. Gastrointestinal Endoscopy 26(1): 13-15, 1980

Magnetic resonance cholangiopancreatography (MRCP) versus endoscopic retrograde cholangiopancreatography (ERCP): diagnostic usefulness. Gastroenterologia Y Hepatologia 21(4): 174-180, 1998

Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 29(3): 182-187, 1997

Common bile duct calculi--ERCP vs laparoscopic exploration: the case for endoscopic retrograde cholangiopancreatography (ERCP). Annals of the Royal College of Surgeons of England 86(6): 470-471, 2004

Diagnostic value of secretin-enhanced magnetic resonance cholangiopancreatography (S-MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Orvosi Hetilap 145(10): 529-534, 2004

Serum molecular forms of trypsin and elastase 1 in acute pancreatitis and endoscopic retrograde cholangiopancreatography. Digestive Diseases & Sciences 29(10): 941, 1984

Addition of gentamicin to endoscopic retrograde cholangiopancreatography (ERCP) contrast medium towards reducing the frequency of septic complications of ERCP. Journal of Digestive Diseases 11(4): 237-243, 2010

Retrospective comparison of magnetic resonance cholangiopancreatography (MRCP) with endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreaticobiliary diseases. 2007

Variation of molecular size distribution of trypsin and elastase 1 serum immunoreactivity after endoscopic retrograde cholangiopancreatography. Digestion 30(2): 82, 1984

Hyperenzymemia and molecular size distribution of trypsin and elastase 1 in the serum after endoscopic retrograde cholangiopancreatography and during acute pancreatitis. Gut 26(6): A649-A650, 1985

Increased serum trypsinogen 2 and trypsin 2-1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography (ERCP)-induced pancreatitis with high accuracy. Gastrointestinal Endoscopy 47(6): 554-555, 1998

Endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic therapy in pancreatic disease. Clinics in Gastroenterology 13(3): 819-842, 1984